Short Description
Quantitatively measures human alanine aminotransferase 1 (ALT/GPT) protein levels using a high-sensitivity sandwich ELISA.
ADME Research Domain
Metabolism
Description
CytoFinal™ High Sensitivity Human Alanine Aminotransferase 1 / ALT (GPT) ELISA Kit enables precise quantification of ALT protein concentrations in human biological samples. Based on a sandwich enzyme-linked immunosorbent assay, the kit utilizes highly specific antibodies to capture and detect ALT1, providing reliable measurement in serum, plasma, and cell culture samples for liver function research and biomarker analysis.
Features
Highly sensitive sandwich ELISA design enables accurate detection of low-abundance ALT protein levels in complex biological matrices.
Specific monoclonal antibody pair ensures strong target recognition with minimal cross-reactivity against related aminotransferase enzymes.
Standard 96-well microplate format allows convenient processing of multiple samples with compatibility across common ELISA plate readers.
Optimized reagents and calibrated standards support reproducible quantification with robust signal stability and excellent assay-to-assay consistency.
Process Relevance
Quantifies ALT protein levels to support biomarker discovery and evaluation of liver injury mechanisms.
Application Stage
Biomarker discovery, translational research, preclinical studies, and clinical sample analysis.
Applications
Quantitative measurement of ALT protein in human serum, plasma, and cell culture samples for liver disease studies, biomarker validation, toxicology assessment, ADME profiling studies, and clinical research.
Target
Human alanine aminotransferase 1 (ALT1/GPT)
Detection Method
Colorimetric
Sample Type
Serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids.
Assay Measures
Quantitative
Research Areas
Hepatology, clinical biomarker research, toxicology, pharmacokinetics (ADME), metabolic disease research, pharmacology, translational medicine, etc.